Inflammation: Targeting inflammatory pathways to treat atherosclerosis and cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed.

1. NLRP3 inflammasome in cardiovascular diseases: molecular mechanisms and advances in targeted drug research.Frontiers in immunology · 2026
   Review
2. Deficient chaperone-mediated autophagy in macrophages aggravates colitis and colitis-associated tumorigenesis in mice.Molecules and cells · 2025
   Article
3. The interplay of DNA damage and repair, gene expression, and mutagenesis in mammalian cells during oxidative stress.Carcinogenesis · 2024
   Article
4. Polyvascular Disease and the Incidence of Cancer in Patients with Coronary Artery Disease.JMA journal · 2022
   Article
5. Mendelian randomization study of interleukin (IL)-1 family and lung cancer.Scientific reports · 2021
   Article
6. Smoking, DNA Methylation, and Breast Cancer: A Mendelian Randomization Study.Frontiers in oncology · 2021
   Article
7. The role of EP-2 receptor expression in cervical intraepithelial neoplasia.Histochemistry and cell biology · 2020
   Article
8. Preoperative endothelial function and long-term cardiovascular events in patients undergoing cardiovascular surgery.Heart and vessels · 2019
   Article
9. Protective Effects of Angong Niuhuang Pill on Early Atherosclerosis in ApoEEvidence-based complementary and alternative medicine : eCAM · 2019
   Article
10. Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer.Mutation research. Reviews in mutation research
    Review

Corrections and comments

• Comment on
  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.2017
• Comment on
  Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as